LOADING
Comparing Merck & Company (MRK) and Boeing Company (BA) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | BA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $279.1B | $182.2B |
| P/E Ratio | 15.5 | 91.8 |
| Forward P/E | 22.0 | 153.8 |
| PEG Ratio | 3.44 | 6.53 |
| EPS | $7.28 | $2.52 |
| Revenue Growth (YoY) | 5.0% | 57.1% |
| Profit Margin | 28.1% | 2.5% |
| Return on Equity | 36.9% | 290.1% |
| Dividend Yield | 2.88% | -- |
| Beta | 0.28 | 1.13 |
| 52-Week High | $124.22 | $254.35 |
| 52-Week Low | $70.74 | $175.86 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.